Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
WCN26-4069 EFFICACY AND SAFETY OF IPTACOPAN IN PARTICIPANTS WITH C3 GLOMERULOPATHY: C3G EXTENSION TRIAL INTERIM RESULTS FROM THE PHASE 3 APPEAR-C3G PARTICIPANTS
C. Nester, Richard J.H. Smith, David Kavanagh, Marina Vivarelli, Giuseppe Remuzzi, Ming-hui Zhao, Edwin K.S. Wong, Y. Wang, Rubeen Israni, Hari Kalluri, Ipsita Krishnan, Jean Grisouard, Andrew S. Bomback (2026). WCN26-4069 EFFICACY AND SAFETY OF IPTACOPAN IN PARTICIPANTS WITH C3 GLOMERULOPATHY: C3G EXTENSION TRIAL INTERIM RESULTS FROM THE PHASE 3 APPEAR-C3G PARTICIPANTS. , 11(4), DOI: https://doi.org/10.1016/j.ekir.2026.106215.
Article15 days agoOral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study
David Kavanagh, Andrew S. Bomback, Marina Vivarelli, Carla Nester, Giuseppe Remuzzi, Ming Zhao, Edwin Wong, Yaqin Wang, Ipsita Krishnan, Imelda Schuhmann, Angelo J. Trapani, Nicholas J.A. Webb, Matthias Meier, Rubeen Israni, Richard J. Smith, A Ramos Espinosa, Rita Marcela Fortunato, Mari Mar Freijo, Nadia Viviana Fretes, Pablo Raffaele, Gianna Mastroianni Kirsztajn, Juliana Mansur Siliano, Laila Almeida Viana, Dervla M. Connaughton, Susan Huang, Faisal Rehman, Pavel Roshanav, M. Lynn Weir, Dong‐Yuan Chang, Pei Chen, Bixia Gao, Ying Tan, Yang Li, Xiaojuan Yu, Xin Zhang, Ming Zhao, Chuan‐Ming Hao, Lingyun Lai, Shaojun Liu, Eva Jančová, Vladimı́r Tesař, Anne Blanchard, Sophie Chauvet, Nathalie Chavarot, Roxane Gaïsset, François Provôt, Myriam Dao, Hamza Sakhi, Aude Servais, Julia Weinmann‐Menke, Ute Eisenberger, Anja Gäckler, Benjamin Wilde, Anne Dieterle, Michael S. Wiesener, Tobias B. Huber, Malte A. Kluger, Eleftheria‐Kleio Dermitzaki, Charikleia Gakiopoulou, Kostas Stylianou, Narayan Prasad, Dharmendra Bhadauria, Dinesh Khullar, Soumita Bagchi, Naomi Ben-Dor, Valeria Morduhovich, Benaya Rozen‐Zvi, Yael Borovitz, Daniel Landau, Camillo Carrara, Erica Daina, Amantia Imeraj, Maddalena Marasà, Piero Ruggenenti, Giuseppe Remuzzi, Luca Antonucci, Marcello Chinali, Antonio Gargiulo, Federica Zotta, Sosuke Fukui, Hangsoo Kim, Masashi Mizuno, Yasuhíro Suzuki, Shin Goto, Michihiro Hosojima, Hideyuki Kabasawa, Yoshikatsu Kaneko, Ryohei Kaseda, Ichiei Narita, Tadashi Otsuka, Hirofumi Watanabe, Suguru Yamamoto, Motoki Matsuki, Naoki Nagakawa, Wataru Ohwada, Arata Osanami, Hidemichi Kouzu, Tomohisa Yamashita, Toshiyuki Yano (2025). Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study. , 406(10512), DOI: https://doi.org/10.1016/s0140-6736(25)01148-1.
Article15 days agoWCN25-2041 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH C3 GLOMERULOPATHY: 12-MONTH RESULTS FROM THE PHASE 3 APPEAR-C3G STUDY
Carla Nester, Richard Smith, David Kavanagh, Marina Vivarelli, Giuseppe Remuzzi, Ming‐Hui Zhao, Edwin Wong, Yaqin Wang, Angelo J. Trapani, Ipsita Krishnan, Nicholas J.A. Webb, Matthias Meier, Andrew S. Bomback (2025). WCN25-2041 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH C3 GLOMERULOPATHY: 12-MONTH RESULTS FROM THE PHASE 3 APPEAR-C3G STUDY. , 10(2), DOI: https://doi.org/10.1016/j.ekir.2024.11.300.
Article15 days agoTrial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN
Fádi Fakhouri, Andrew S. Bomback, Gema Ariceta, Yahsou Delmas, Bradley P. Dixon, Daniel P. Gale, Larry A. Greenbaum, Seung Hyeok Han, Nicole M. Isbel, Moglie Le Quintrec, Christoph Licht, Antonio Mastrangelo, Masashi Mizuno, Maria Izabel Neves de Holanda, Matthew C. Pickering, Giuseppe Remuzzi, Nicole C. A. J. van de Kar, Marina Vivarelli, Patrick D. Walker, Dean Wallace, Daniel Zecher, Cedric Francois, Pascal Deschatelets, Li Li, Zhongshen Wang, Lydia Abad‐Franch, Nils Kinnman, Luis López Lázaro, Johan Szamosi, Carla Nester (2025). Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN. , 393(22), DOI: https://doi.org/10.1056/nejmoa2501510.
Article15 days agoVALIANT: Randomized, multicenter, double-blind, placebo-controlled, phase 3 trial of pegcetacoplan for patients with native or post-transplant recurrent C3G or primary (idiopathic) IC-MPGN
Carla Nester, Andrew S. Bomback, Gema Ariceta, Yahsou Delmas, Bradley P. Dixon, Daniel P. Gale, Larry A. Greenbaum, Seung Hyeok Han, Nicole M. Isbel, Christoph Licht, Antonio Mastrangelo, Masashi Mizuno, Maria Izabel Neves de Holanda, Matthew C. Pickering, Giuseppe Remuzzi, Nicole C. A. J. van de Kar, Marina Vivarelli, Patrick D. Walker, Dean Wallace, Daniel Zecher, Li Li, Zhongshen Wang, Luis López Lázaro, Johan Szamosi, Fádi Fakhouri (2025). VALIANT: Randomized, multicenter, double-blind, placebo-controlled, phase 3 trial of pegcetacoplan for patients with native or post-transplant recurrent C3G or primary (idiopathic) IC-MPGN. , 230(4), DOI: https://doi.org/10.1016/j.imbio.2025.153039.
Article15 days ago